Envista Holdings Corp (NVST)
Full history for every metric is available with a Kvantra account
No price history available.
Key financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 1,929 | 2,509 | 2,569 | 2,567 | 2,511 | 2,720 | 2,857 | 2,881 |
| Operating profit | $m | 226 | 283 | ||||||
| Net profit | $m | 33 | 341 | 243 | -100 | -1,119 | 47 | 95 | 258 |
| EPS reported | $ | 0.28 | 0.58 | ||||||
| Operating cashflow per share | $ | 1.64 | 1.85 | ||||||
| Capex per share | $ | 0.27 | 0.41 | ||||||
| FCF per share | $ | 1.37 | 1.43 | ||||||
| Free cash flow | $m | 230 | 232 | ||||||
| Net debt | $m | 237 | 311 | ||||||
| Book value equity | $m | 3,106 | 3,076 | ||||||
| Book value per share | $ | 18.36 | 18.75 | ||||||
| Number of shares | m | 169.2 | 164.1 | ||||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | 77.54 | 41.29 | ||||||
| P/B LTM | x | 1.17 | 1.19 | ||||||
| P/S LTM | x | 1.34 | 1.28 | ||||||
| P/FCF LTM | x | 15.83 | 15.70 | ||||||
| EV/EBITDA LTM | x | 12.23 | 11.48 | ||||||
| EV/Sales LTM | x | 1.48 | 1.60 | ||||||
| Earnings Yield LTM | % | +1.29% | +2.42% | ||||||
| FCF Yield | % | +6.32% | +6.37% | ||||||
| Quality | |||||||||
| ROE | % | +1.51% | +4.10% | ||||||
| ROIC | % | +1.23% | +23819.7% | ||||||
| Operating margin | % | +8.30% | +9.92% | ||||||
| Gross margin | % | +55.02% | +55.50% | ||||||
| FCF/Sales | % | +8.47% | +8.13% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | - | - | ||||||
| Sales Growth YoY | % | +8.32% | +13.78% | ||||||
| Net Income Growth YoY | % | - | - | ||||||
| FCF Growth | % | -23.89% | -23.26% | ||||||
| Operating Profit Growth | % | - | - | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.00% | 0.00% | ||||||
| Dividend Growth | % | - | - | ||||||
| Payout Ratio | % | 0.00% | 0.00% | ||||||
| FCF/Debt | x | 0.14 | 0.15 | ||||||
| Net Debt/EBITDA | x | 1.17 | 0.00 | ||||||
| EBIT/Net interest | x | 6.17 | 13.76 | ||||||
| Net debt/market cap | % | +39.71% | +0.00% | ||||||
| Net debt/Equity | x | 0.08 | 0.10 | ||||||
| Gross debt/equity | x | 0.51 | 0.52 | ||||||
Price target estimates
Based on consensus from external analysts. Not Kvantra's opinion.
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
ESG
| Metric | 2024 | 2025 | 2026 |
|---|---|---|---|
| ESG-score | |||
| Environmental score | |||
| Social score | |||
| Governance score | |||
| Risk rating |
Company overview
Envista Holdings Corporation is an enterprise dedicated to the development and distribution of a comprehensive range of dental solutions. These offerings are crucial for the identification, therapeutic intervention, and preventative care of diverse oral health issues, specifically addressing the teeth, gingiva (gums), and their supporting bone structures. The company's principal location is in Brea, California, and it maintains a workforce comprising 12,800 full-time personnel. The firm organizes its business activities into two main divisions: "Specialty Products & Technologies" and "Equipment & Consumables." The Specialty Products & Technologies division concentrates on the creation, fabrication, and promotion of sophisticated dental implant systems, advanced prosthetic devices, and their associated digital treatment software and technological advancements. This segment also provides orthodontic remedies, including bracket systems, clear aligners, and various items for dental laboratories. Conversely, the Equipment & Consumables division is responsible for conceptualizing, producing, and bringing to market a wide array of dental apparatus and vital supplies intended for professional dental clinics. This extensive catalog includes digital imaging instruments, specialized software, and visual or magnification systems; patient treatment units and other essential fixtures for dental practices; complete endodontic kits along with their complementary consumable items; materials and tools for restorative dentistry; rotary cutting tools (burs); impression-making compounds; adhesive agents and dental cements; and products designed for infection control.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Consensus from external analysts. Not Kvantra's opinion.
Based on consensus from external analysts. Not Kvantra's opinion.
Envista Holdings Corporation is an enterprise dedicated to the development and distribution of a comprehensive range of dental solutions. These offerings are crucial for the identification, therapeutic intervention, and preventative care of diverse oral health issues, specifically addressing the teeth, gingiva (gums), and their supporting bone structures. The company's principal location is in Brea, California, and it maintains a workforce comprising 12,800 full-time personnel. The firm organizes its business activities into two main divisions: "Specialty Products & Technologies" and "Equipment & Consumables." The Specialty Products & Technologies division concentrates on the creation, fabrication, and promotion of sophisticated dental implant systems, advanced prosthetic devices, and their associated digital treatment software and technological advancements. This segment also provides orthodontic remedies, including bracket systems, clear aligners, and various items for dental laboratories. Conversely, the Equipment & Consumables division is responsible for conceptualizing, producing, and bringing to market a wide array of dental apparatus and vital supplies intended for professional dental clinics. This extensive catalog includes digital imaging instruments, specialized software, and visual or magnification systems; patient treatment units and other essential fixtures for dental practices; complete endodontic kits along with their complementary consumable items; materials and tools for restorative dentistry; rotary cutting tools (burs); impression-making compounds; adhesive agents and dental cements; and products designed for infection control.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free